TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/23/23 17:53 | 5/22/23 | OMER | Omeros Corp | WA | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | WA | D | M.d | 27 | 5.30 | 0 | 5 | 68 | 12 | D | |||||||||||||||
5/23/23 17:53 | 5/22/23 | OMER | Omeros Corp | WA | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | WA | D | S.d | -32 | 6.46 | 0 | -5 | -29 | 12 | D | |||||||||||||||
6/6/22 20:33 | 6/3/22 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | TX | D | P | 5 | 0.1840 | 0 | 28 | 153 | 46 | I | |||||||||||||||
6/6/22 20:31 | 8/21/20 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | TX | D | P.a | 4 | 0.9800 | 0 | 4 | 54 | 11 | I | |||||||||||||||
6/6/22 20:28 | 2/11/20 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | TX | D | P.a | 5 | 1.15 | 0 | 4 | 145 | 7 | I | |||||||||||||||
6/6/22 20:27 | 11/25/19 | SLRX | Salarius Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hanish Arnold C | TX | D | P.a | 11 | 3.59 | 0 | 3 | New | 3 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |